Literature DB >> 19467018

Cyclin D1 expression in typical chronic lymphocytic leukaemia.

Zaid Abboudi1, Ketan Patel, Kikkeri N Naresh.   

Abstract

Demonstration of cyclin D1 expression by immunohistochemistry in a CD5-positive small B-cell proliferation is extremely helpful in the diagnosis of mantle cell lymphoma in tissue samples, including bone marrow trephine biopsies (BMTB) and in differentiating them from chronic lymphocytic leukaemia (CLL). Following the identification of cyclin D1 expression in one case of CLL on BMTB, 64 additional cases, which included 25 lymph nodes, one tonsillar lesion, one skin lesion and 37 BMTBs were systematically reviewed for presence of cyclin D1 overexpression. Overall, in seven of 65 samples (approximately 10%) of CLL, a minority of the leukaemic cells in the proliferation centres expressed cyclin D1. Cytogenetic analysis had been performed in three of seven cases and there was no evidence of translocation involving CCND1 locus. Our findings suggest that a small subset of CLL overexpresses cyclin D1 in amounts that can be demonstrated by immunohistochemistry. Our observation has impact on the diagnosis of small B-cell lymphomas in BMTB and other tissue samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467018     DOI: 10.1111/j.1600-0609.2009.01276.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  4 in total

1.  Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies.

Authors:  Jess F Peterson; Linda B Baughn; Rhett P Ketterling; Beth A Pitel; Stephanie A Smoley; George Vasmatzis; James B Smadbeck; Patricia T Greipp; Abhishek A Mangaonkar; Carrie A Thompson; Sameer A Parikh; Dong Chen; David S Viswanatha
Journal:  Blood Adv       Date:  2019-04-23

2.  Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.

Authors:  Joel F Gradowski; Rachel L Sargent; Fiona E Craig; Kathleen Cieply; Kim Fuhrer; Carol Sherer; Steven H Swerdlow
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

Review 3.  Cell cyclins: triggering elements of cancer or not?

Authors:  Michael Stamatakos; Victoria Palla; Ioannis Karaiskos; Konstantinos Xiromeritis; Ioannis Alexiou; Ioannis Pateras; Konstantinos Kontzoglou
Journal:  World J Surg Oncol       Date:  2010-12-22       Impact factor: 2.754

4.  SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement.

Authors:  Małgorzata Szostakowska; Michał Szymczyk; Kalina Badowska; Barbara Tudek; Anna Fabisiewicz
Journal:  Med Oncol       Date:  2018-03-08       Impact factor: 3.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.